Issue 2/1999
Content (8 Articles)
Challenges to the Economic Evaluation of New Biotechnological Interventions in Healthcare
James Mason
A Review of Quality-of-Life Evaluations in Prostate Cancer
Sunshine D. Sommers, Scott D. Ramsey
Review of Quality-of-Life Evaluations in Patients with Angina Pectoris
Afschin Gandjour, Karl W. Lauterbach
Cost Effectiveness of Riluzole in Amyotrophic Lateral Sclerosis
Andrea Messori, Sabrina Trippoli, Paola Becagli, Gaetano Zaccara
Estimating Long Term Cost Savings from Treatment of Alzheimer’s Disease
Paul Fenn, Alastair Gray
The Influence of Hospital-Based Prescribers on Prescribing in General Practice
John Feely, Robert Chan, John McManus, Brendan O’Shea
Cost Comparison of Antibacterial Therapies for Serious Infections
Guy Scott, Helen M. Scott, Seton Henderson, Alison Inder, Joanne Sanders, Ruth Spearing, Colin McArthur, James Judson, Bartrum Baker, Peter Hicks, Philippa Cotterell
Choice of Cost-Effectiveness Measure in the Economic Evaluation of Cholesterol-Modifying Pharmacotherapy
Stephen Morris, Ed Godber